Cargando…
Mesenchymal stem cells modified by FGF21 and GLP1 ameliorate lipid metabolism while reducing blood glucose in type 2 diabetic mice
OBJECTIVE: The purpose of this study was to investigate the therapeutic effects of genetically modified mesenchymal stem cells (MSCs) in the treatment of type 2 diabetes mellitus (T2DM) in order to identify a new method for treating diabetes that differs from traditional medicine and to provide a ne...
Autores principales: | Xue, Binghua, Xiao, Xiuxiao, Yu, Tingting, Xiao, Xinhua, Xie, Jing, Ji, Qiuhe, Wang, Li, Na, Tao, Meng, Shufang, Qian, Lingjia, Duan, Haifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885588/ https://www.ncbi.nlm.nih.gov/pubmed/33588950 http://dx.doi.org/10.1186/s13287-021-02205-z |
Ejemplares similares
-
Plasma FGF21 concentrations are regulated by glucose independently of insulin and GLP-1 in lean, healthy humans
por: Solomon, Thomas P.J., et al.
Publicado: (2022) -
K27Q/K29Q mutations in sphingosine kinase 1 attenuate high-fat diet induced obesity and altered glucose homeostasis in mice
por: Xie, Jing, et al.
Publicado: (2020) -
Propofol Improved Glucose Tolerance Associated with Increased FGF-21 and GLP-1 Production in Male Sprague-Dawley Rats
por: Wu, Chih-Cheng, et al.
Publicado: (2020) -
A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis
por: Pan, Qi, et al.
Publicado: (2021) -
FGF21 ameliorates the neurocontrol of blood pressure in the high fructose-drinking rats
por: He, Jian-Li, et al.
Publicado: (2016)